Related Experiment Videos
[Mechanism of spasmolytic action of 4-methylumbelliferone]
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|March 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department.
QJM : monthly journal of the Association of Physicians·2023
Safety of Elderly Living Kidney Donors: 2 Cases of Donors Older Than 80 Years: A Case Report.
Transplantation proceedings·2018
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
[Pharmacological properties and clinical efficacy of bempedoic acid (NEXLETOL® tablets 180 mg) for the treatment of hypercholesterolemia].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
[Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity® 2 mg tablets)].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
[A novel human 3D steatohepatitis model recapitulating disease progression for evaluating the efficacy and mechanism of action of MASH therapeutics].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
[Prediction of drug intestinal absorption and drug-induced intestinal toxicity with the use of human crypt-derived intestinal stem cells and their differentiated cells].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
[Current progress in brain organoid research for human biology].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
[Revolutionizing physiology: advances in organ-on-a-chip technology].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Clustered cytoneme interactions contribute to peripheral nervous system patterning in Drosophila.
bioRxiv : the preprint server for biology·2026
Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy.
bioRxiv : the preprint server for biology·2026
Characterizing two nanobodies for SMAD4.
FEBS letters·2026
Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.
Clinical pharmacology and therapeutics·2026